AIP and obesity due to melanocortin 4 receptor deficiency: Elevated levels of AIP are strongly associated with obstructive sleep apnea, insulin resistance, type 2 diabetes, newly diagnosed hypertension, carotid atherosclerosis, and obesity (6, 22–27).